Insiders / Torley Helen / Activity
Activity — Torley Helen
41 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $1.24M | -19K -2.41% | 768,780 0.68% of shares | medium |
| Jun 2, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $1.10M | -17K -2.11% | 771,180 0.68% of shares | medium |
| Mar 2, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $1.07M | -15K -1.96% | 768,358 0.68% of shares | medium |
| Apr 2, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $1.01M | -16K -2.01% | 771,980 0.68% of shares | medium |
| Mar 3, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $928.2K | -13K -1.71% | 774,299 0.68% of shares | medium |
| Jun 1, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $875.6K | -13K -1.65% | 773,181 0.68% of shares | medium |
| Feb 4, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $783.2K | -10K -1.41% | 708,719 0.62% of shares | medium |
| Feb 4, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $761.7K | -10K -1.36% | 718,819 0.63% of shares | medium |
| Feb 3, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $733.5K | -10K -1.33% | 716,509 0.63% of shares | medium |
| May 12, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $699.6K | -10K -1.25% | 776,480 0.68% of shares | medium |
| May 11, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $628.5K | -10K -1.23% | 778,055 0.69% of shares | medium |
| Feb 3, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $597.8K | -8K -1.09% | 708,719 0.62% of shares | medium |
| Mar 4, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $512.6K | -7K -0.94% | 770,451 0.68% of shares | medium |
| Mar 3, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $452.0K | -7K -0.84% | 767,780 0.68% of shares | medium |
| May 11, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $444.4K | -7K -0.87% | 767,780 0.68% of shares | medium |
| May 12, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $425.7K | -6K -0.76% | 770,580 0.68% of shares | medium |
| Jun 3, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $425.1K | -6K -0.79% | 767,780 0.68% of shares | medium |
| Feb 5, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $421.4K | -5K -0.75% | 713,343 0.63% of shares | medium |
| Apr 6, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $372.5K | -6K -0.76% | 771,880 0.68% of shares | medium |
| Jun 1, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $369.1K | -5K -0.70% | 767,780 0.68% of shares | medium |
| Feb 5, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $365.0K | -5K -0.65% | 708,719 0.62% of shares | medium |
| Mar 2, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $283.7K | -4K -0.52% | 783,680 0.69% of shares | medium |
| May 13, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $275.7K | -4K -0.51% | 768,380 0.68% of shares | medium |
| Apr 2, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $272.5K | -4K -0.54% | 767,780 0.68% of shares | medium |
| Apr 6, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $262.5K | -4K -0.53% | 767,780 0.68% of shares | medium |
| May 11, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $234.0K | -4K -0.46% | 774,480 0.68% of shares | medium |
| May 13, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $230.7K | -3K -0.43% | 772,330 0.68% of shares | medium |
| Jun 2, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $226.9K | -3K -0.44% | 767,780 0.68% of shares | medium |
| May 12, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $204.7K | -3K -0.36% | 767,780 0.68% of shares | medium |
| Feb 3, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $191.0K | -3K -0.35% | 726,168 0.64% of shares | medium |
| Mar 4, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $189.5K | -3K -0.35% | 767,780 0.68% of shares | medium |
| May 13, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $143.0K | -2K -0.27% | 775,680 0.68% of shares | medium |
| Jun 3, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $137.5K | -2K -0.26% | 773,880 0.68% of shares | medium |
| Jun 1, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $106.9K | -2K -0.20% | 786,170 0.69% of shares | medium |
| Jun 3, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $101.5K | -2K -0.19% | 775,880 0.68% of shares | medium |
| May 12, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $98.3K | -1K -0.18% | 786,282 0.69% of shares | low |
| Apr 1, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $65.7K | -1K -0.13% | 767,780 0.68% of shares | low |
| May 13, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $42.5K | -600 -0.08% | 767,780 0.68% of shares | low |
| Mar 2, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $40.7K | -578 -0.08% | 767,780 0.68% of shares | low |
| Jun 3, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $26.5K | -400 -0.05% | 777,380 0.68% of shares | low |
| May 12, 2026 | Sell | HALO Halozyme Therapeutics Inc Common Stock | $6.8K | -100 -0.01% | 787,680 0.69% of shares | low |